NRx Pharmaceuticals, Inc. (NRXP) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.29M | -3.71M | -2.89M | -4.03M | -3.48M | -1.46M | -2.31M | -3.5M | -3.67M | -3.19M | -4.56M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.01M | -14.23M |
| Operating CF Margin % | -402.15% | -377.72% | -1194.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -23.42% | -153.62% | -25.37% | -14.92% | 5.2% | 54.14% | 49.47% | 55.13% | 39.71% | 61.63% | 27.16% | 47.18% | 41.34% | 26.26% | 47.85% | -3.95% | -244.28% | -2673.48% | -963.25% | -2082.94% |
| Net Income | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -20.77M | -117.61K |
| Depreciation & Amortization | 165K | 100K | 41K | 0 | 0 | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395 | 638 | 967 |
| Stock-Based Compensation | 151K | 81K | 0 | 67K | 12K | 43K | 104K | 97K | 242K | -1.2M | 351K | 544K | 695K | 766K | 541K | 987K | 1.33M | 1.57M | 1.56M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 260.24K | 0 |
| Other Non-Cash Items | -3.51M | -5.61M | 2.39M | 14M | 2.02M | 7.02M | -1.14M | 2.19M | 327K | -80K | 359K | 924K | 1.76M | 486K | 37K | -2.6M | -2.26M | 18.88M | 8.34M | -11.5M |
| Working Capital Changes | 331K | 1.36M | 567K | -516K | 0 | 548K | 352K | 2.1M | 2.29M | 2.42M | 812K | -564K | 2.49M | 670K | 2.24M | -6.2M | 3.99M | -937.76K | -1.4M | -2.62M |
| Change in Receivables | -48K | 36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -390 | 831.39K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.48M | 0 |
| Change in Payables | 129K | 0 | 601K | -679K | 178K | 0 | 740K | 2.12M | 2.09M | 1M | 1.52M | -1.57M | 1.7M | -92K | -910K | -1.23M | 624K | -1.87M | -708.91K | 0 |
| Cash from Investing | -213K | -249K | -2.56M | 0 | 0 | 0 | 0 | 0 | 0 | 1K | -2K | 2K | -4K | 1K | -5K | -3K | -3K | -388 | -3.83K | -2.78K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | -2K | 2K | -4K | 1K | -5K | -3K | -3K | -388 | -3.83K | -2.78K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 183K | -2.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.42M | 4.58M | 9.73M | 1.39M | 7.58M | 1.26M | 2.05M | 4.08M | 395K | -1.12M | -1.5M | 6.27M | 2.54M | 10.12M | -28K | -860K | 22.98M | 1.24K | 37.52M | 25.76M |
| Debt Issued (Net) | 0 | 2.93M | -225K | 378K | 4.68M | 3.32M | -533K | 942K | -2.15M | -1.12M | -2.67M | 696K | 0 | 10.02M | 0 | 0 | 0 | 474 | -176.47K | -1.28M |
| Equity Issued (Net) | 3.42M | 1.64M | 9.95M | 1.01M | 3.25M | -2.06M | 219K | 3.14M | 2.55M | 0 | 1.17M | 5.58M | 2.54M | 92K | -28K | -342K | 22.98M | 878 | 37.69M | 15.99M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 1K | -1K | 0 | -350K | 0 | 2.37M | 0 | 0 | 0 | 0 | 0 | 0 | 10K | 0 | -518K | 0 | -117 | 0 | 11.05M |
| Net Change in Cash | -1.08M | 613K | 4.27M | -2.64M | 4.11M | -203K | -252K | 579K | -3.28M | -4.31M | -6.07M | -1.54M | -3.55M | 1.8M | -6.3M | -15.65M | 12.6M | -11.28M | 25.5M | 13.39M |
| Free Cash Flow | -4.29M | -3.71M | -2.89M | -4.03M | -3.48M | -1.46M | -2.31M | -3.5M | -3.67M | -3.19M | -4.57M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.02M | -14.23M |
| FCF Margin % | -402.15% | -377.72% | -1194.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -23.42% | -153.62% | -25.37% | -14.92% | 5.2% | 54.12% | 49.5% | 55.12% | 39.75% | 61.63% | 27.19% | 47.21% | 41.32% | 26.27% | 47.82% | -3.95% | -244.38% | -2660% | -963.59% | -2083.36% |
| FCF per Share | -0.13 | -0.12 | -0.13 | -0.22 | -0.21 | -0.14 | -0.21 | -0.33 | -0.41 | -0.04 | -0.56 | -0.11 | -0.09 | -0.13 | -0.09 | -0.23 | -0.16 | -0.22 | -0.22 | -0.33 |
| FCF Conversion (FCF/Net Income) | 3.00x | -10.31x | 0.49x | 0.23x | 0.63x | 0.16x | 1.42x | 0.44x | 0.56x | 0.74x | 0.75x | 0.90x | 0.55x | 0.81x | 0.69x | 2.12x | 0.77x | 0.37x | 0.32x | 120.98x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 374K | 239K | 0 | 205K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |